期刊文献+

芪葛效灵丹治疗脑梗死86例临床观察

Clinical observation of treating 86 cases of cerebral infarction with Qige effective remedy
下载PDF
导出
摘要 目的:对采用芪葛效灵丹治疗脑梗死进行临床效果观察。方法:抽取在2007年1月至2011年5月我科确诊为脑梗死的172例住院患者病例,将其分为治疗组和对照组,治疗组采用芪葛效灵丹治疗,对照组单纯采用西医治疗,对两组患者的临床效果,并发症、不良反应、复发情况等进行比较分析,观察两组疗效。结果:对照组有效率80%,治疗组有效率为91.5%,明显高于对照组。结论:芪葛效灵丹治疗脑梗死临床疗效确切,具有治疗彻底、后遗症少、康复快、复发率低的特点,可以作为中医治疗脑梗死的首选方药,值得进一步的使用和推广。 Objective:To Qige Xiao the best treatment for cerebral infarction observe clinical effect.Methods:extraction in January 2007 to May 2011,I confirmed for cerebral infarction of 172 cases of hospitalized patients with the cases,divided into the treatment group and control group,the treatment group and control group in Qi GeXiao miracle treatment only with western medicine therapy,two groups of patients,complications,the clinical effect of adverse reactions,recurrence and compared the two groups,observe the curative effect.Results:the effective rate was 80% in treatment group and control group rate of 91.5%,significantly higher than those in the control group.Conclusion:Qi GeXiao miracle treatment cerebral infarction clinical curative effect,has thoroughly,exact treatment,quicker recovery less sequela,the recurrence rate is low,the characteristics of Chinese medicine treatment can be used as the first choice of cerebral infarction,therefore,treatment is worth further use and promotion.
作者 伍渊伟
机构地区 永州市中医院
出处 《中医临床研究》 2011年第22期45-46,共2页 Clinical Journal Of Chinese Medicine
关键词 芪葛效灵丹 脑梗死 中医治疗 Qige Xiao miracle Cerebral infarction TCM
  • 相关文献

参考文献5

  • 1中华神经学会 中华神经外科学会.各类脑血管疾病诊断要点.中华神经科杂志,2006,:60-61.
  • 2中华神经学会 中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准(2005).中华神经科杂志,2006,:62-64.
  • 3国家中医药管理局.中医病证诊断疗效标准[M].北京:人民卫生出版社,2006:214.
  • 4丁宏岩,董强.自由基清除剂依达拉奉对脑缺血的治疗作用[J].国外医学(脑血管疾病分册),2004,12(7):491-493. 被引量:231
  • 5贺茂林 陈清棠.溶栓治疗急性脑梗死的现状和进展.国外医学脑血管分册,2005,:186-186.

二级参考文献13

  • 1Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCJ-186), on acute brain infarction.Randomized, lacebo-controlled, double-blind study at multicenters.Cerebrovasc Dis, 2003, 15: 222 - 229.
  • 2Takamatsu Y, Yuki S, Watanabe T. Studies on the concentration of 3 -methyl-1-1 phenyl-2-pyrazolin-5 -one (MCI-186) in MCA occlusion and reperfusion model of rats. Jpn Pharmacol Ther, 1997, 25(Suppl): S1785 - S1791.
  • 3Jin YJ, Mima T, Raicu V, et al. Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. Neurosci Res, 2002, 43:75 -79.
  • 4Felberg RA, Burgin WS, Grotta JC. Neuroprotection and the ischemic cascade. CNS Spectrums, 2000, 5:52 -58.
  • 5Takabatake Y, Uno E, Wakamatsu K, et al. The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction. No To Shinkei, 2003, 55:589 -593.
  • 6Tatsushi K, Yasuo K. Mild hypothermia enhances efficacy ofneuroprotective agents in cerebral ischemia in rats. International Congress Series, 2003, 1252:93 - 101.
  • 7Charriaut-Marlangue C, Margaill I, Represa A, et al. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J Cereb Blood Flow Metab, 1996, 16:186 - 194.
  • 8Li Y, Chopp M, Jiang N, et al. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Met. ab, 1995, 15:389 -397.
  • 9Peters O, Back T, Lindauer U, et al. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab, 1998, 18:196 -205.
  • 10Toyoda T, Kassell NF, Lee KS. Attenuation of ischemia-reperfusion injury in the neocortex by the hydroxyl radical scavenger nicaraven.Neurosurgery, 1997, 40:372 -378.

共引文献235

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部